Helium is a new entrant in the pharmaceutical business that is in the process of acquiring branded products for markets in Africa, Central Asia and the South eastern markets. We hope to focus on long term disease areas concentrated around Gastroenterology, Psychiatry, Diabetes and Cardiology. Our business model includes development of a state of the art production facility, foreign collaborations and business growth through strong and intelligent branding. Our sister concern Helix Pharma (Pvt) Ltd is already manufacturing under license of Takeda, since 1921, has developed a reputation for aggressive marketing in the area of infectious diseases.